2016 – Page 9

The use of assistive devices is ineffective for multiple sclerosis (MS) patients, a study recently presented at the Consortium of Multiple [...]

0

CMSC 2016 Annual Meeting – Fingolimod (Gilenya) offers consistent health benefits in RRMS patients

CMSC PR, Partners

Researchers at the Swedish Neuroscience Institute in Washington and Novartis Pharma revealed that Gilenya (fingolimod) induced a [...]

0

‘Multiple sclerosis does not remit’ – call to change RRMS name to relapsing multiple sclerosis

INforMS, MS Community

MS does not remit and the out dated term causes many people to delay taking medication, says Dr Patricia Coyle, Founder and Director of [...]

0

CMSC 2016 Annual Meeting – multiple sclerosis mice show reduced disease severity after treatment with vegetable compound

CMSC PR

Research from Indiana University School of Medicine showed that D3T – a compound that triggers copying of antioxidant genes and [...]

0

CMSC 2016 Annual Meeting – multiple sclerosis patients, physical therapists have distinct decision-making processes

CMSC PR, Partners

Understanding and combining decision-making processes of both patients with multiple sclerosis (MS) and physical therapists to improve [...]

0

CMSC 2016 Annual Meeting – home DVD-guided exercise may help older multiple sclerosis patients

CMSC PR

Positive results from a home-based exercise intervention designed to target flexibility, toning, and balance for older adults with multiple [...]

0

CMSC 2016 Annual Meeting – multiple sclerosis duration and disability level variously impacts arm function

CMSC PR, Partners

Most research in multiple sclerosis (MS) has focused on the impact of the disease on the lower extremities. To balance this, researchers [...]

0

CMSC 2016 Annual Meeting – multiple sclerosis and yoga: author and instructor says ancient discipline can help patients

CMSC PR, Partners

Mindy Eisenberg is the author of the book “Adaptive Yoga Moves Any Body” and Multiple Sclerosis News Today had the chance to hear [...]

0

CMSC 2016 Annual Meeting – Ocrevus (Ocrelizumab) in PPMS prevented disability progression

CMSC PR, Partners

Data recently presented at the Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting showed that Roche/Genentech’s [...]

0

CMSC 2016 Annual Meeting – Genentech’s Ocrelizumab a promising therapy for primary progressive multiple sclerosis

CMSC PR

Genentech, a member of the Roche Group, was founded more than 35 years ago and has been focused on a variety of research fields, including [...]

Elizabeth Porco

24

0

Yearly Archives: "2016"

Recent Posts

Contact Us

Feel Free To contact Us